| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.130 | 7.521 | 8.918 | 6.542 | 0 | 10.341 | 9.032 | 0 | 0 | 0 |
| Total Income - EUR | 2.130 | 7.521 | 8.918 | 6.921 | 0 | 10.341 | 9.032 | 0 | 0 | 0 |
| Total Expenses - EUR | 2.632 | 4.366 | 10.092 | 629 | 5.303 | 3.515 | 2.181 | 818 | 0 | 0 |
| Gross Profit/Loss - EUR | -502 | 3.155 | -1.174 | 6.292 | -5.303 | 6.825 | 6.851 | -818 | 0 | 0 |
| Net Profit/Loss - EUR | -502 | 3.155 | -1.174 | 6.281 | -5.303 | 6.825 | 6.851 | -818 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Bio Espino Amarillo Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 30.452 | 33.110 | 32.550 | 35.762 | 35.069 | 34.404 | 33.641 | 33.746 | 33.643 | 33.455 |
| Current Assets | 17.762 | 28.751 | 31.372 | 34.434 | 22.473 | 23.671 | 25.331 | 25.444 | 25.366 | 25.225 |
| Inventories | 0 | 0 | 5.473 | 5.372 | 5.268 | 5.168 | 5.054 | 5.069 | 5.054 | 5.026 |
| Receivables | 12.550 | 23.866 | 16.263 | 17.210 | 16.895 | 16.575 | 16.207 | 16.258 | 16.208 | 16.118 |
| Cash | 5.212 | 4.885 | 9.637 | 11.852 | 309 | 1.928 | 4.070 | 4.116 | 4.104 | 4.081 |
| Shareholders Funds | -4.452 | -1.251 | -2.404 | 3.921 | -1.458 | 5.395 | 12.126 | 11.346 | 11.311 | 11.248 |
| Social Capital | 180 | 178 | 175 | 172 | 169 | 165 | 162 | 162 | 162 | 161 |
| Debts | 52.666 | 63.112 | 66.326 | 66.275 | 59.000 | 52.681 | 46.847 | 47.843 | 47.698 | 47.432 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "128 - 128" | |||||||||
| CAEN Financial Year |
128
|
|||||||||
Comments - Bio Espino Amarillo Srl